<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 09-Nov-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (09-Nov-2025)</h1>
<hr />
<h2>Key News Highlights</h2>
<ul>
<li><strong>Government Shutdown Fallout:</strong> Ongoing shutdown causing FAA air traffic cuts, significant flight cancellations, and mounting economic costs. Consumer sentiment dampened; shutdown effects described as &quot;worse than expected&quot; by government.</li>
<li><strong>Healthcare Developments:</strong> Supreme Court allows temporary halt of full SNAP (food stamp) aid; policy uncertainty for consumer staples. Senate Republicans push for big ACA (Obamacare) changes; Trump advocates sending subsidies “directly to people.”</li>
<li><strong>Energy &amp; Utilities:</strong> Sharp voter backlash over surging electricity bills. AI/data center power demand is a major factor; utilities under scrutiny for rate increases tied to tech expansion.</li>
<li><strong>Global Security/Upset:</strong> Russia conducted missile/drone barrage on Ukraine, inflicting casualties &amp; energy grid hits. Brazil tornado and ongoing Sudan, West Bank instability highlight continued global crisis/disaster risk.</li>
<li><strong>Corporate Activity:</strong> Pfizer to acquire obesity drug Metsera ($10B), besting Novo Nordisk—escalating the anti-obesity pharma race.</li>
</ul>
<hr />
<h2>Macro Environment</h2>
<h3>US Economic Outlook</h3>
<ul>
<li><strong>Growth</strong>: GDP remains in moderately positive territory for Q4 2025, with low likelihood of negative growth or recession within next two quarters. The economy is generally on a &quot;soft landing&quot; path, with solid employment and moderate inflation.</li>
<li><strong>Rates</strong>: Federal Reserve is expected to implement a sequence of modest rate cuts through 2025, with the market most focused on a “cut-cut-cut” sequence over the next several meetings.</li>
<li><strong>Fiscal Uncertainty</strong>: Ongoing government shutdown is already causing negative spillover into sectors reliant on federal activity (transport, air travel, contracting, some consumer confidence metrics). Appropriations bills are likely, but legislative delays or new standoffs remain plausible.</li>
</ul>
<p><strong>Second Order Effects:</strong></p>
<ul>
<li>Persistent shutdowns hurt consumer discretionary and travel/airlines sectors and heighten risk for delayed infrastructure or R&amp;D appropriations (e.g., NASA, FAA).</li>
<li>Shutdown-induced air traffic disruptions create pressure on broader service, hospitality, and cargo logistics industries, potentially delaying revenues and raising insurance risks.</li>
</ul>
<h3>Inflation &amp; Employment</h3>
<ul>
<li><strong>Inflation</strong>: Core and headline CPI are likely to hold between 2.6%–3.5% into late 2025. Wage growth is running above headline inflation, supporting consumer resilience. Goods and food price volatility remains a concern, with food stamps’ uncertainty adding downside risk to lower-income consumption.</li>
<li><strong>Labor Market</strong>: Unemployment is expected to remain contained, despite bouts of high-profile layoffs (especially in government/contractor-heavy sectors due to shutdowns). No major spike in national unemployment rates forecast in the near term.</li>
</ul>
<h3>Policy &amp; Geopolitical Risks</h3>
<ul>
<li><strong>US Policy:</strong> ACA reform, changes to SNAP, and energy transition initiatives are politically live and subject to headline-driven volatility. Corporate and capital gains tax frameworks remain steady, with low odds for sudden hikes or cuts.</li>
<li><strong>Tariffs &amp; Trade:</strong> Potential for new, more aggressive tariffs on China, EU, Mexico, Canada, and Asian manufacturing countries. Key US trading partners are bracing for unpredictable policies, with tariffs on semiconductors, pharma, and alternative energy components in discussion.
<ul>
<li><strong>Second Order</strong>: Supply chain constraints for US manufacturing (especially auto, EV, and tech hardware); upside pressure on US manufacturing and &quot;re-shoring&quot; themes.</li>
</ul>
</li>
<li><strong>China &amp; Russia:</strong> Military escalation risk is present but not high-probability in the near term. Energy and commodity disruptions can reemerge if aggression intensifies or new sanctions are imposed.</li>
<li><strong>Climate &amp; Disaster:</strong> Weather disruptions (eg. tornadoes in Brazil, persistent extreme heat records) and AI-induced power demand may accelerate insurance claims and utility volatility—raising the profile of catastrophe-exposed sectors.</li>
</ul>
<hr />
<h2>Sectoral &amp; Asset Class Implications</h2>
<h3>Equities (US &amp; Global)</h3>
<ul>
<li><strong>Broad Indices:</strong> Markets are positioned for continued, if choppy, gains with technology (AI, semiconductors), mega-caps, and defensives leading.
<ul>
<li>Circuit breaker risk and marketwide volatility events remain low but nonzero, especially in the face of exogenous shocks (macro, geopolitical, extreme weather, regulatory).</li>
</ul>
</li>
<li><strong>Tech/AI/Semiconductors:</strong> Tech sector leadership is robust, driven by AI model gains and relentless data center/compute demand. NVIDIA’s runaway scale-up is likely to persist, with other mega-caps (Apple, MSFT, Amazon, Google, Meta) stable.
<ul>
<li>Watch continued antitrust attention for Apple, Amazon, and Meta.</li>
</ul>
</li>
<li><strong>Consumer Discretionary &amp; Retail:</strong> Risks from SNAP halts and ongoing political wrangling over healthcare and welfare may impact lower-tier discretionary spending.
<ul>
<li>Disney steady as an earnings outperformer, retail names buoyed by resilient wage trends and strong employment.</li>
</ul>
</li>
<li><strong>Energy &amp; Utilities:</strong> Higher-for-longer energy bills and AI/data center-driven demand pose both opportunity (for utilities, grid suppliers) and backlash/regulatory risk. Oil and natgas prices remain rangebound.
<ul>
<li>Second Order: Watch for mounting political pressure on utilities to curb or justify rate hikes.</li>
</ul>
</li>
<li><strong>Healthcare/Biotech:</strong> Obesity drug race intensifies with Pfizer-Metsera and Novo-Nordisk activity; ongoing M&amp;A in sector. Healthcare/tax policy uncertainty introduces some headline volatility, but core trends remain favorable.</li>
<li><strong>Financials:</strong> Macro risks (shutdown, trade, FX, tariffs) present persistent headline risk but no systemic stability concerns in near-term.</li>
</ul>
<h3>Fixed Income</h3>
<ul>
<li><strong>Treasuries:</strong> Path for rates is down but gradual; little near-term risk of a return to ultra-low yields. Marginal, slow softening in yields forecast into 2026.</li>
<li><strong>TIPS &amp; Inflation Protection:</strong> Likely to underperform as inflation expectations cool, but real rates may remain attractive if inflation stays at or just above 3%.</li>
<li><strong>Credit:</strong> No major bankruptcy wave anticipated, but shutdown and trade volatility could cause an uptick in high-yield distress, concentrated in consumer/retail/transport.</li>
</ul>
<h3>Commodities</h3>
<ul>
<li><strong>Energy:</strong> Oil/natural gas are holding steady on mixed signals; neither a supply collapse nor major spike is on the horizon but Middle East/Ukrainian escalation could rapidly change the scenario.</li>
<li><strong>Gold:</strong> Remains favored as a volatility and credit risk hedge, outperforming bitcoin in the short-term.</li>
<li><strong>Ags/Insurance:</strong> Ongoing climate shocks (heat, hurricanes, tornadoes) increase insurance claim risk and may impact crop/commodity balances late in the season.</li>
</ul>
<h3>Crypto &amp; Alternatives</h3>
<ul>
<li><strong>Bitcoin/Ethereum:</strong> Both likely to be rangebound, crypto retracing some gains and underperforming gold near-term. Regulatory progress remains slow; institutional/country-level adoption lazy.</li>
<li><strong>Stablecoins:</strong> Little risk of major depegging in the next month. Crypto/DeFi sector newsflow will be dominated by new token launches, moderate airdrop hype, and a persistent focus on transparency/security in the wake of sporadic hacks.</li>
<li><strong>M&amp;A/IPO Pipeline:</strong> Major AI, fintech, and HR tech IPOs are on the horizon but unlikely to materialize in 2025; public-to-private transitions in crypto and AI are slow.</li>
</ul>
<hr />
<h2>Notable Individual Names/Events</h2>
<ul>
<li><strong>Nvidia</strong>: Poised to remain top global company by market cap; sector leadership in chips/AI persists. Short-term risk from antitrust or export policy remains but is not market-moving.</li>
<li><strong>Pfizer / Novo Nordisk</strong>: Pharma M&amp;A heats up; expanded obesity drug pipeline arms race continues.</li>
<li><strong>Apple / Amazon / Microsoft / Meta / Alphabet</strong>: Regulatory risk remains on antitrust but existential shakeups are unlikely.</li>
<li><strong>Tesla</strong>: Volatility high around production/delivery targets and regulatory developments; leadership stable and EV sector steady but not overheating.</li>
<li><strong>Walmart/Disney</strong>: Retail and entertainment defensives remain well-supported, benefiting from wage growth above inflation, but exposed to SNAP and political swings.</li>
<li><strong>Warner Bros. Discovery, Paramount, Comcast</strong>: Consolidation speculation remains in media sector; high deal probability but regulatory review could delay outcomes.</li>
<li><strong>Banks</strong>: No systemic risk, but headline sensitivity to government shutdown, policy uncertainty, and trade-related issues.</li>
</ul>
<hr />
<h2>Tactical Takeaways</h2>
<ol>
<li><strong>Stay Overweight Tech and AI/Compute-Intensive Utilities:</strong> Sustained data center/AI demand is a secular growth driver; utilities and grid infrastructure benefit, but manage rising regulation/price risk.</li>
<li><strong>Be Selective in Consumer Discretionary, Defensive in Staples:</strong> Policy volatility (SNAP, ACA reforms) presents downside for low-end discretionary spending; focus on higher-income and staple-exposed names.</li>
<li><strong>Consider Rotating Into Insurance/Disaster Hedging Products:</strong> Recent disasters, weather extremes, and ongoing global disorder raise the opportunity in insurance and catastrophe bonds.</li>
<li><strong>Lean into Pharma/Healthcare on M&amp;A and Innovation:</strong> Obesity drug M&amp;A trend and gene therapy/CRISPR innovation are spurring sector outperformance; monitor for further pipeline deals.</li>
<li><strong>Keep Cautious Exposure to Transportation, Travel, and Government-Dependent Contractors:</strong> FAA/air traffic issues and federal funding standoffs pose operational and headline risks.</li>
<li><strong>Monitor Geopolitical and Trade Risks:</strong> Fast-evolving situations in the Russia-Ukraine war, Middle East, and US tariff policy will dictate episodes of volatility, especially for commodities and manufacturing.</li>
<li><strong>Gold Favored Over Crypto in Current Risk-On Pulse:</strong> Gold continues as preferred macro hedge; crypto lacks major tailwinds near-term.</li>
</ol>
<hr />
<p><em>For further granularity or sector-specific notes, please advise focus or time horizon as appropriate.</em></p>

</main>
</body>
</html>
